BETH ISRAEL DEACONESS MEDICAL CENTER
Multi-Omics Correlates of Broadly Neutralizing Antibody Efficacy
Multi-Omics Correlates of Broadly Neutralizing Antibody Efficacy is a funding opportunity from BETH ISRAEL DEACONESS MEDICAL CENTER, up to 276640, closing April 30, 2028.
Apr 30, 2028
(639d left)Overview
SUMMARY Accumulating data suggests that administration of broadly neutralizing antibodies (bNAbs) in ART-suppressed, SHIV-infected nonhuman primates (NHPs) and HIV-1-infected humans can delay viral rebound following ART discontinuation. However, the mechanism underlying the efficacy of bNAbs remains to be determined.…